By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


GlycoMimetics, Inc. 

14915 Broschart Road, Suite 200

Rockville   Maryland  20850  U.S.A.
Phone: 301-738-1166 Fax:




Company News
GlycoMimetics, Inc. (GLYC) Signs A Long Term Lease For A Bigger Space In Maryland 10/21/2014 8:20:27 AM
GlycoMimetics, Inc. (GLYC) To Present At Biotechnology Industry Organization (BIO) Investor Forum 10/5/2014 9:01:28 AM
Pfizer (PFE) Delays Start Of Phase 3 Rivipansel Trial, GlycoMimetics, Inc. (GLYC) Shares Fall 9/26/2014 7:34:44 AM
GlycoMimetics, Inc. (GLYC) To Present At Biocentury's 21st Annual Newsmakers In The Biotech Industry Conference 9/22/2014 8:07:40 AM
Data On GlycoMimetics, Inc. (GLYC)' Drug Candidate's Potential To Treat Lung Infections Caused By Pseudomonas Aeruginosa To Be Presented At North American Cystic Fibrosis Conference 9/9/2014 7:24:42 AM
GlycoMimetics, Inc. (GLYC) To Present at 34th Annual Canaccord Genuity Global Growth Conference 8/8/2014 9:24:46 AM
GlycoMimetics, Inc. (GLYC) Reports Second Quarter 2014 Results 8/1/2014 8:56:45 AM
GlycoMimetics, Inc. (GLYC) Appoints Mark A. Goldberg, M.D. To Board of Directors 7/10/2014 11:21:54 AM
GlycoMimetics, Inc. (GLYC) Announces Agreement With FDA On Special Protocol Assessment For Phase 3 Clinical Trial Of Rivipansel (GMI-1070) 7/1/2014 11:00:36 AM
GlycoMimetics, Inc. (GLYC) Initiates First Clinical Trial Of GMI-1271 As Potential Treatment For Blood-Related Cancers 6/19/2014 9:19:26 AM